Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Andrew Hore
twitter
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.
IPO Analysis
Media Tech SPAC launches PrimaryBid offer
IPO Analysis
New AIM admission: Silver Bullet Data Services
IPO Analysis
New AIM admission: itim Group
Premium
New strategy outlined for Dignity
Funds & Trusts
Specialist Fund Segment admission: Literacy Capital
Premium
Victoria acquisition adds online expertise
IPO Analysis
New AIM admission: Victorian Plumbing
IPO Analysis
New AIM admission: Spectral MD
IPO Analysis
New AIM admission: Thor Explorations Ltd
Premium
NMCN secures refinancing from a familiar face
Premium
Dignity strategy to be unveiled at AGM
IPO Analysis
New premium listing: Made.com
Premium
Open Orphan finalises Poolbeg Pharma spin-off
Premium
Best of the Best share price slumps despite special dividend
Premium
Director dealing: Sportingbet founder tops up online gaming holding
Premium
boohoo sales comparatives get tougher
Premium
Revolting shareholders: Morrisons directors’ not thought to be good value
Premium
AB Traction adds to Driver stake
AQUIS
New Aquis admission: Clarify Pharma
Premium
JLEN NAV falls, but dividend remains attractive
Premium
FTSE 250 index constituents’ dividend attractions
IPO Analysis
New standard listing: Thungela Resources
IPO Analysis
Aquis to Main Market: ImperialX / CloudBreak Discovery
Premium
TIP: The AIM share preventing hospital infections
IPO Analysis
New AIM admission: Artisanal Spirits
Premium
Director dealings: Emmerson
AQUIS
New Aquis admission: TECC Capital
IPO Analysis
New AIM admission: Arecor Therapeutics
AQUIS
New Aquis admission: Pioneer Media Holdings Inc
IPO Analysis
New AIM admission: Belluscura
Load more
Xpeng – the Tesla rival whose shares have rallied 315% in two months
23/11/2020
‘End of Austerity’ promise hashed out during PMQs
10/10/2018
Brexit: 5,000 City jobs could leave UK
10/10/2018
Advanced Oncotherapy shares soar after cancer treatment milestone
10/10/2018
Two reasons Travelodge backers can expect sleepless nights
24/07/2020